Canadian Pharma Cohort — 10-K filings dated 2026-02-19 through 2026-03-27

Lede

No forensic event signals fired across this five-name cohort and no event-tagged bullets were extracted from any of the filings. What is left is a linguistic dispersion map, and the map is not uniform: NUVB and FENC are layering hedging into the sections where investors price risk, BHC concentrates its hedging in risk factors and MD&A, AUPH clusters tentative language around the financial statements, and ZYME registers as anomalously certain in the same registers where the rest of the cohort hedges. This is a measurement-only read.

Findings

1. NUVB — disclaimer saturation in Item 5 and Item 3

The Item 5 (market for equity) language sits well above industry p95 on disclaimer density [Market for Registrant's Common Equity Disclaimer density NUVB = 37.209, baseline p95 = 30.708], tentative markers [Market for Registrant's Common Equity · Hedging language · NUVB = 13.953 — above the 95th percentile], and forward-looking orientation [Market for Registrant's Common Equity Forward-looking framing NUVB = 55.814, baseline p95 = 49.353]. Item 3 (legal proceedings) compounds the pattern [Legal Proceedings Disclaimer density NUVB = 14.388, baseline p95 = 12.230] alongside an Item 3 future-focus reading [Legal Proceedings · Forward-looking framing · NUVB = 43.165 — above the 95th percentile] that is unusual for a section that conventionally describes existing matters. Item 9A vague attribution is also above the cohort baseline [Controls and Procedures · Vague attributions · NUVB = 0.599 — above the 95th percentile]. The hedging is location-specific and convergent on liquidity- and legal-adjacent disclosure.

2. FENC — hedging cluster in the business description

The Item 1 business description carries the cohort's highest hedging load [Business overview Disclaimer density FENC = 1.101, baseline p95 = 0.932; Business overview Hedging language FENC = 13.579, baseline p95 = 13.240]. Item 7A (quantitative and qualitative disclosures about market risk) repeats the pattern at an even higher relative magnitude [Quantitative & Qualitative Disclosures About Market Risk Disclaimer density FENC = 3.390, baseline p95 = 2.712]. Item 1 is the section where issuers typically speak with the most confidence about what they do; FENC does not.

3. ZYME — anomalous certainty where peers hedge

ZYME is the cohort's inverse outlier. Item 1 certainty balance sits above industry p95 [Business overview Certainty / hedge imbalance ZYME = 0.500, baseline p95 = 0.448] while tentative markers and disclaimers in the same section are at the cohort floor [Business overview Hedging language ZYME = 1.136, bottom 10%; Business overview Disclaimer density ZYME = 0.000, bottom 10%]. Cliché density in Item 1 is above p95 [Business overview Cliché density ZYME = 0.568, baseline p95 = 0.454], and Item 2 pulls forward-looking language far above the cohort [Properties Forward-looking framing ZYME = 33.766, baseline p95 = 27.765; Properties Hedging language ZYME = 10.390, above the 95th percentile]. Certainty co-located with elevated cliché density warrants surfacing on the linguistic axis.

4. AUPH — tentative-marker concentration in MD&A-adjacent sections

Tentative language concentrates in unresolved staff comments, market-risk disclosure, and the financial statements [Unresolved Staff Comments Hedging language AUPH = 13.025, above the 95th percentile; Quantitative & Qualitative Disclosures About Market Risk Hedging language AUPH = 15.625, above the 95th percentile; Financial Statements Hedging language AUPH = 4.528, baseline p95 = 4.269]. Item 8 vague attribution sits more than 20% above the industry p95 [Financial Statements Vague attributions AUPH = 2.264, baseline p95 = 1.865]. Item 3 certainty balance prints at the cohort floor [Legal Proceedings · Certainty / hedge imbalance · AUPH = 0.000 — bottom 10%].

5. BHC — split signature: low-certainty Item 1, hedged Item 1A and Item 7

Item 1 certainty balance sits below p10 [Business overview · Certainty / hedge imbalance · BHC = 0.113 — bottom 10%] while the risk-factors and MD&A sections carry the hedging weight [Risk Factors Disclaimer density BHC = 1.140, baseline p95 = 1.126; Risk Factors Hedging language BHC = 14.107, baseline p95 = 13.826; MD&A Hedging language BHC = 13.480, baseline p95 = 12.278]. Item 9A controls language reads heavily passive [Controls and Procedures Passive voice ratio BHC = 1.754, baseline p95 = 1.731].

Forensic note

Across this cohort the diagnostic question is not how much hedging the filings carry but where it is located. Disclaimer density and tentative markers cluster in section-specific registers per issuer — Item 5 for NUVB [Market for Registrant's Common Equity · Disclaimer density · NUVB = 37.209], Item 1 and Item 7A for FENC [Business overview Disclaimer density FENC = 1.101; Quantitative & Qualitative Disclosures About Market Risk Disclaimer density FENC = 3.390], Items 1B/7A/8 for AUPH [Financial Statements · Vague attributions · AUPH = 2.264], and Items 1A/7 for BHC [Risk Factors · Hedging language · BHC = 14.107]. ZYME runs the opposite signature in the same registers [Business overview Certainty / hedge imbalance ZYME = 0.500; Business overview Hedging language ZYME = 1.136], with cliché density at p95 [Business overview · Cliché density · ZYME = 0.568], which is the linguistic profile of templated confidence rather than the absence of risk. No event bullets attach to any of these readings in the current evidence layer; the report is a pure-linguistics read and should be treated as such.

What to watch

Next filing cycle, the measurable questions are narrow. Does NUVB's Item 5 disclaimer and future-focus density normalize toward the cohort mean or extend further, and does an event bullet — going-concern, covenant, or financing language — finally attach to the registers already running above p95 [Market for Registrant's Common Equity Disclaimer density NUVB = 37.209; Market for Registrant's Common Equity Forward-looking framing NUVB = 55.814]. Does FENC's Item 1 hedging migrate into Item 7 MD&A, the conventional path when business-description uncertainty becomes operating uncertainty [Business overview · Hedging language · FENC = 13.579]. Does ZYME's certainty profile hold or revert, particularly whether Item 1 cliché density falls [Business overview · Cliché density · ZYME = 0.568] — a drop alongside sustained low tentative markers would distinguish substantive confidence from boilerplate. And does AUPH's Item 8 vague attribution stay above p95 [Financial Statements · Vague attributions · AUPH = 2.264], with attention to whether any auditor or controls disclosure follows the language already on the page.